P-1853. Peripheral blood monocytes pro-inflammatory and anti-inflammatory cytokine release in elderly patients with heart failure with reduced ejection fraction

Abstract Background Heart failure with reduced ejection fraction (HFrEF) has benn reported to characterize by sub-clinical inflammation status. There are few reports about changes in selected biomarkers of inflammation concomitant with the release of pro-inflammatory and anti-inflammatory cytokines by monocyte in elderly patients with HFrEF. Methods We measured plasma levels of the cytokines in 62 elderly Japanese HFrEF patients (aged 85.8 ± 2.7 years, left ventricular ejection fraction 33.7 ± 3.5%) and 20 healthy controls. Peripheral blood monocytes (PBM) obtained from HFrEF patients were stimulated by LPS (10 μg/ml) in the absence or the presence of adenosine (10 μmol/l). After 6hr incubation, the cytokines levels in the culture supernatants were measured by ELISA. Results Plasma levels of TNF-alpha, IL-6, IL-10, and IL-12p40 were significantly greater in HFrEF patients than in controls. Plasma IL-12p40 levels of HFrEF patients showed significant correlations with IL-6 and IL-10. In vitro study, adenosine inhibited the generation of pro-inflammatory cytokines from LPS-stimulated PBM (TNF-alpha: 764.2±32.3 to 242.5±55.3pg/ml, IL-6: 82.3±13.5 to 21.4±4.2 pg/ml, IL-12p40: 164.8±23.5 to 18.2±5.1, all p< 0.01), while it augmented IL-10 generation (29.2±6.1 to 54.9±7.8pg/ml, p< 0.01) significantly. Conclusion Our data indicated plasma levels of pro-inflammatory and anti-inflammatory cytokine were elevated in eldely patients with HFrEF relating. Adenosine may represent a new pharmacological intervention in such HFrEF patients,the clinical significance of these findings deserves further investigation Disclosures All Authors: No reported disclosures

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2025-01-29
DOI
https://doi.org/10.1093/ofid/ofae631.2014
Primary Topic
Heart Failure Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

P-1853. Peripheral blood monocytes pro-inflammatory and anti-inflammatory cytokine release in elderly patients with heart failure with reduced ejection fraction

Yasuhiko Mitsuke, Kazuhiro Itoh, Hiromichi Iwasaki
Open Forum Infectious Diseases
Heart Failure Treatment and Management
article

P-1853. Peripheral blood monocytes pro-inflammatory and anti-inflammatory cytokine release in elderly patients with heart failure with reduced ejection fraction

Yasuhiko Mitsuke, Kazuhiro Itoh, Hiromichi Iwasaki
article en

Abstract

Abstract Background Heart failure with reduced ejection fraction (HFrEF) has benn reported to characterize by sub-clinical inflammation status. There are few reports about changes in selected biomarkers of inflammation concomitant with the release of pro-inflammatory and anti-inflammatory cytokines by monocyte in elderly patients with HFrEF. Methods We measured plasma levels of the cytokines in 62 elderly Japanese HFrEF patients (aged 85.8 ± 2.7 years, left ventricular ejection fraction 33.7 ± 3.5%) and 20 healthy controls. Peripheral blood monocytes (PBM) obtained from HFrEF patients were stimulated by LPS (10 μg/ml) in the absence or the presence of adenosine (10 μmol/l). After 6hr incubation, the cytokines levels in the culture supernatants were measured by ELISA. Results Plasma levels of TNF-alpha, IL-6, IL-10, and IL-12p40 were significantly greater in HFrEF patients than in controls. Plasma IL-12p40 levels of HFrEF patients showed significant correlations with IL-6 and IL-10. In vitro study, adenosine inhibited the generation of pro-inflammatory cytokines from LPS-stimulated PBM (TNF-alpha: 764.2±32.3 to 242.5±55.3pg/ml, IL-6: 82.3±13.5 to 21.4±4.2 pg/ml, IL-12p40: 164.8±23.5 to 18.2±5.1, all p< 0.01), while it augmented IL-10 generation (29.2±6.1 to 54.9±7.8pg/ml, p< 0.01) significantly. Conclusion Our data indicated plasma levels of pro-inflammatory and anti-inflammatory cytokine were elevated in eldely patients with HFrEF relating. Adenosine may represent a new pharmacological intervention in such HFrEF patients,the clinical significance of these findings deserves further investigation Disclosures All Authors: No reported disclosures

Open Forum Infectious DiseasesVol. 12(Supplement_1)
University of Fukui Hospital (JP), Kawamura Hospital (JP)
Openalex Percentile: Top 97%
Heart Failure Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.